• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ocular Surface Changes in Primary Open Angle Glaucoma with Long Term Topical Anti Glaucoma Medication.长期局部使用抗青光眼药物的原发性开角型青光眼患者的眼表变化
Med J Armed Forces India. 2007 Oct;63(4):341-5. doi: 10.1016/S0377-1237(07)80011-6. Epub 2011 Jul 21.
2
Adverse effects of topical antiglaucoma drugs on the ocular surface.局部抗青光眼药物对眼表的不良反应。
Clin Exp Ophthalmol. 2000 Apr;28(2):113-7. doi: 10.1046/j.1442-9071.2000.00237.x.
3
Effects of antiglaucoma drugs on ocular surface.抗青光眼药物对眼表的影响。
Acta Ophthalmol Scand. 1995 Jun;73(3):246-8. doi: 10.1111/j.1600-0420.1995.tb00277.x.
4
Effects of topical antiglaucoma application on conjunctival impression cytology specimens.局部抗青光眼药物应用对结膜印迹细胞学标本的影响。
Am J Ophthalmol. 2006 Jul;142(1):185-6. doi: 10.1016/j.ajo.2006.02.056.
5
Clinico-cytological analysis of conjunctiva and ocular surface symptoms of patients on topical anti-glaucoma medications attending Lagos University Teaching Hospital, Lagos, Nigeria: A case-control study.尼日利亚拉各斯拉各斯大学教学医院局部使用抗青光眼药物患者结膜及眼表症状的临床细胞学分析:一项病例对照研究
Niger Postgrad Med J. 2023 Jul-Sep;30(3):240-249. doi: 10.4103/npmj.npmj_99_23.
6
The effects of long-term topical glaucoma medication on conjunctival impression cytology.长期局部使用青光眼药物对结膜印迹细胞学的影响。
Int Ophthalmol. 1997;21(1):27-33. doi: 10.1023/a:1005892426045.
7
Ocular surface changes induced by topical antiglaucoma monotherapy.局部抗青光眼单一疗法引起的眼表变化
Ophthalmologica. 2002 May-Jun;216(3):175-9. doi: 10.1159/000059624.
8
Ocular surface alteration after long-term treatment with an antiglaucomatous drug.长期使用抗青光眼药物后的眼表改变。
Ophthalmology. 1992 Jul;99(7):1082-8. doi: 10.1016/s0161-6420(92)31847-0.
9
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.从含防腐剂的前列腺素制剂转换为不含防腐剂的前列腺素制剂在局部青光眼药物治疗中的应用。
Acta Ophthalmol. 2010 May;88(3):329-36. doi: 10.1111/j.1755-3768.2010.01907.x.
10
Ocular surface disorders and tear function changes in patients with chronic renal failure.慢性肾衰竭患者的眼表疾病与泪液功能变化
Can J Ophthalmol. 2004 Aug;39(5):526-32. doi: 10.1016/s0008-4182(04)80143-1.

引用本文的文献

1
Ocular surface changes in primary open-angle glaucoma on anti-glaucoma medications versus treatment-naïve patients.抗青光眼药物治疗与未经治疗的原发性开角型青光眼患者的眼表变化。
Indian J Ophthalmol. 2024 Mar 1;72(3):374-380. doi: 10.4103/IJO.IJO_618_23. Epub 2023 Dec 15.
2
Glaucoma and Dry Eye Disease: Opportunity to Assess and Treat.青光眼与干眼病:评估与治疗的契机。
Clin Ophthalmol. 2023 Oct 17;17:3063-3076. doi: 10.2147/OPTH.S420932. eCollection 2023.
3
Glaucoma and Ocular Surface Disease: More than Meets the Eye.青光眼与眼表疾病:不止于所见
Clin Ophthalmol. 2022 Nov 4;16:3641-3649. doi: 10.2147/OPTH.S388886. eCollection 2022.
4
A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.抗青光眼药物相关眼表疾病的叙述性综述
Ophthalmol Ther. 2022 Oct;11(5):1681-1704. doi: 10.1007/s40123-022-00557-0. Epub 2022 Aug 9.
5
Impact of Ocular Surface Disease Treatment in Patients with Glaucoma.青光眼患者眼表疾病治疗的影响
Clin Ophthalmol. 2020 Jan 14;14:103-111. doi: 10.2147/OPTH.S229815. eCollection 2020.
6
Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation.酒石酸溴莫尼定纳米囊制剂治疗青光眼的研究:体外与体内评价。
AAPS PharmSciTech. 2011 Jun;12(2):755-63. doi: 10.1208/s12249-011-9643-9. Epub 2011 Jun 14.

本文引用的文献

1
Influence of beta-adrenergic antagonists on tear secretion in children.β-肾上腺素能拮抗剂对儿童泪液分泌的影响。
Pol J Pharmacol. 2004 Nov-Dec;56(6):871-3.
2
Conjunctival impression cytology in contact lens wearers.隐形眼镜佩戴者的结膜印迹细胞学检查
Indian J Ophthalmol. 2002 Dec;50(4):301-6.
3
Ocular surface changes induced by topical antiglaucoma monotherapy.局部抗青光眼单一疗法引起的眼表变化
Ophthalmologica. 2002 May-Jun;216(3):175-9. doi: 10.1159/000059624.
4
Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis.局部应用拉坦前列素和噻吗洛尔引起的眼表变化:对伴有和不伴有过敏性结膜炎的青光眼患者的短期研究
Graefes Arch Clin Exp Ophthalmol. 2001 Nov;239(11):809-14. doi: 10.1007/s004170100328.
5
Adverse effects of topical antiglaucoma drugs on the ocular surface.局部抗青光眼药物对眼表的不良反应。
Clin Exp Ophthalmol. 2000 Apr;28(2):113-7. doi: 10.1046/j.1442-9071.2000.00237.x.
6
Side effects of antiglaucomatous drugs on the ocular surface.抗青光眼药物对眼表的副作用。
Curr Opin Ophthalmol. 1996 Apr;7(2):80-6. doi: 10.1097/00055735-199604000-00014.
7
Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group.酒石酸溴莫尼定0.2%每日两次与噻吗洛尔0.5%每日两次对比:青光眼患者的1年研究结果。溴莫尼定研究组
Am J Ophthalmol. 1999 Jan;127(1):20-6. doi: 10.1016/s0002-9394(98)00286-4.
8
Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.健康志愿者中含与不含苯扎氯铵的2%卡替洛尔局部用药的短期对比研究。
Br J Ophthalmol. 1998 Jan;82(1):39-42. doi: 10.1136/bjo.82.1.39.
9
Effect of timolol with and without preservative on the basal tear turnover in glaucoma.含与不含防腐剂的噻吗洛尔对青光眼患者基础泪液更新的影响。
Br J Ophthalmol. 1995 Apr;79(4):339-42. doi: 10.1136/bjo.79.4.339.
10
Ocular surface alteration after long-term treatment with an antiglaucomatous drug.长期使用抗青光眼药物后的眼表改变。
Ophthalmology. 1992 Jul;99(7):1082-8. doi: 10.1016/s0161-6420(92)31847-0.

长期局部使用抗青光眼药物的原发性开角型青光眼患者的眼表变化

Ocular Surface Changes in Primary Open Angle Glaucoma with Long Term Topical Anti Glaucoma Medication.

作者信息

Kamath A P, Satyanarayana S, Rodrigues Fea

机构信息

Senior Advisor (Ophthalmology), Command Hospital (EC), Kolkata -700027.

Ex-Classified Specialist (Ophthalmology) Command Hospital (NC), C/o 56 APO.

出版信息

Med J Armed Forces India. 2007 Oct;63(4):341-5. doi: 10.1016/S0377-1237(07)80011-6. Epub 2011 Jul 21.

DOI:10.1016/S0377-1237(07)80011-6
PMID:27408045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4922031/
Abstract

BACKGROUND

Topical life long anti glaucoma medication forms the mainstay of treatment of primary open angle glaucoma. Their long term usage can cause changes in conjunctival epithelium.

METHODS

Hundred cases of primary open angle glaucoma were divided into four groups of 25 patients each. Each group was put on Timolol, Pilocarpine, Brimonidine and Latanoprost respectively. Ocular surface changes were monitored using Schirmer's test, tear film break up time (BUT) and conjunctival impression cytology.

RESULT

Altered Schirmer's test value was seen in 40% of patients and reduced tear film BUT values in 26%, at the end of one year. These changes were more in patients treated with timolol. Changes in conjunctival cytology such as decrease in goblet cell density, squamous metaplasia and presence of inflammatory cells were seen in significant number of patients at the end of one year treatment. There was direct relation of duration of treatment to various ocular surface changes.

CONCLUSION

Ocular surface changes are seen in significant number of patients of primary open angle glaucoma at the end of one year follow up with topical anti glaucoma therapy. Conjunctival impression cytology is a non invasive technique to monitor these changes.

摘要

背景

局部长期使用抗青光眼药物是原发性开角型青光眼治疗的主要手段。其长期使用可导致结膜上皮发生变化。

方法

将100例原发性开角型青光眼患者分为四组,每组25例。每组分别使用噻吗洛尔、毛果芸香碱、溴莫尼定和拉坦前列素。使用泪液分泌试验、泪膜破裂时间(BUT)和结膜印迹细胞学检查来监测眼表变化。

结果

一年后,40%的患者泪液分泌试验值发生改变,26%的患者泪膜破裂时间缩短。噻吗洛尔治疗的患者这些变化更为明显。一年治疗结束时,大量患者出现结膜细胞学改变,如杯状细胞密度降低、鳞状化生和炎性细胞出现。治疗持续时间与各种眼表变化存在直接关系。

结论

在局部抗青光眼治疗一年随访结束时,大量原发性开角型青光眼患者出现眼表变化。结膜印迹细胞学检查是监测这些变化的一种非侵入性技术。